Twitter Facebook LinkedIn WhatsApp Press Releases Any 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 (-) 2011 2010 2009 Reset 2011 November 30, 2011 arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B round November 29, 2011 arGEN-X is awarded €1.3 million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform for Addressing Challenging Disease Targets September 6, 2011 arGEN-X presents significant progress at Biopharm America 2011 July 25, 2011 arGEN-X announces non-exclusive license with BioWa for Potelligent® technology May 15, 2011 arGEN-X initiates a second pre-clinical development program in under 18 months from start of operations January 4, 2011 arGEN-X signs discovery and development alliance with Lilly
